ACCELERATE DIAGNOSTICS INC (AXDX) Stock Price & Overview
NASDAQ:AXDX • US00430H2013
Current stock price
The current stock price of AXDX is 0.034 USD. Today AXDX is down by -61.36%. In the past month the price decreased by -93.7%. In the past year, price decreased by -96.15%.
AXDX Key Statistics
- Market Cap
- 857.14K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.38
- Dividend Yield
- N/A
AXDX Stock Performance
AXDX Stock Chart
AXDX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AXDX. When comparing the yearly performance of all stocks, AXDX is a bad performer in the overall market: 99.85% of all stocks are doing better.
AXDX Earnings
On May 22, 2025 AXDX reported an EPS of -0.38 and a revenue of 2.82M. The company beat EPS expectations (25.49% surprise) and missed revenue expectations (-8.57% surprise).
AXDX Forecast & Estimates
For the next year, analysts expect an EPS growth of 14.29% and a revenue growth 3.44% for AXDX
AXDX Groups
Sector & Classification
AXDX Financial Highlights
Over the last trailing twelve months AXDX reported a non-GAAP Earnings per Share(EPS) of -2.38. The EPS increased by 35.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -175.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AXDX Ownership
AXDX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 40.38 | 171.27B | ||
| ABT | ABBOTT LABORATORIES | 14.77 | 158.354B | ||
| SYK | STRYKER CORP | 21.76 | 125.43B | ||
| BSX | BOSTON SCIENTIFIC CORP | 15.19 | 92.247B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.74 | 48.516B | ||
| IDXX | IDEXX LABORATORIES INC | 38.83 | 44.946B | ||
| BDX | BECTON DICKINSON AND CO | 11.01 | 43.32B | ||
| RMD | RESMED INC | 18.08 | 32.028B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.64 | 31.406B | ||
| DXCM | DEXCOM INC | 24.15 | 23.696B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.92 | 17.665B | ||
| PODD | INSULET CORP | 29.04 | 13.129B | ||
| PEN | PENUMBRA INC | 64.35 | 12.971B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AXDX
Company Profile
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Denver, Colorado and currently employs 107 full-time employees. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company Info
IPO: 1993-10-27
ACCELERATE DIAGNOSTICS INC
3950 S Country Club Rd Ste 470 Bldg 3-307
Denver COLORADO 85714 US
CEO: Jack Phillips
Employees: 107
Phone: 13038638088
ACCELERATE DIAGNOSTICS INC / AXDX FAQ
Can you describe the business of ACCELERATE DIAGNOSTICS INC?
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Denver, Colorado and currently employs 107 full-time employees. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Can you provide the latest stock price for ACCELERATE DIAGNOSTICS INC?
The current stock price of AXDX is 0.034 USD. The price decreased by -61.36% in the last trading session.
Does AXDX stock pay dividends?
AXDX does not pay a dividend.
What is the ChartMill technical and fundamental rating of AXDX stock?
AXDX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the PE ratio for AXDX stock?
ACCELERATE DIAGNOSTICS INC (AXDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.38).
Can you provide the market cap for ACCELERATE DIAGNOSTICS INC?
ACCELERATE DIAGNOSTICS INC (AXDX) has a market capitalization of 857.14K USD. This makes AXDX a Nano Cap stock.